| Medical Condition | Idiopathic Pulmonary Fibrosis (IPF) |
| Facility/Clinic | Accellacare – 1222 Medical Center Dr |
| Age | 18+ |
| Gender | Male & Female |
| Description | A phase 2 study to evaluate the efficacy and safety of GSK3915393 in participants with idiopathic pulmonary fibrosis (IPF). |
| Enrollment | Open |
| Patient Commitment Duration | 7 months |
| Number of visits in study | 9 |
| Patient Compensation | $100-$196/visit (varies per visit) |
The team at WH Research can guide interested clinical research participants through the process of enrolling in a trial.
Please call 910-799-5500 between the hours of 8am-5pm for general research questions.